Cobalis Corp. (fka CLSC)

[randychub]

"Lets say that the data presented was inconclusive. There wasnt enough difference between the participants taking placebo and Prehistin. But both reported scores of 1 or 2s"

Mike as has been posted here many times over the last few months that was the case with Dvax. A large number of the patients recruited only had mild allergies vs having severe allergies. Patient in placebo and drug groups, had close to the same scores which caused their trial to fail. At least that is what they reported.

For Cobalis it has to be something more. They have to be able to prove that the data entered by the patients was entered in correctly or somehow corrupted after the data was entered.

If they have written diaries or key entry diaries that do not match up with the data on the database used to calculate the trial results, that would be the ticket.

Randy